Clinical trial

GEfitinib Plus viNOrelbine in Advanced EGFR Mutated NSCLC. GENOA Trial

NCT02319577

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2012-03-01

PhasePHASE2

Study timeline

Study start (unknown)2012-03-01Date precision: month

Registry last updated2014-12-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non Small Cell Lung Cancerunresolved

Interventions

oral vinorelbineDRUG

GefitinibDRUG · verified · RxNorm: gefitinib

Sponsors & collaborators

IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02319577 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.